Comment to the ADVANCE (Action in diabetes and vascular disease: preterAx and diamicroN-MR controlled evaluation) study
2007
Abstract
Analysis of the ADVANCE study, where indication of 1 tbl Prestarium Combi in patients with type 2 diabetes reduced the incidence of micro- and macro-vascular complications significancy.